ABCB5-positive limbal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABCB5-positive limbal stem cells, covering 2022-10-07 to 2022-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD [Phase 1, Phase 2]